{"id":"https://genegraph.clinicalgenome.org/r/0ea9726e-acef-4a04-9024-fc10d8796195v1.0","type":"EvidenceStrengthAssertion","dc:description":"The ENPP1 gene is located on chromosome 6 at 6q23.2 and encodes the ectonucleotide pyrophosphatase/phosphodiesterase 1 protein, which catalyzes the hydrolysis of ATP to AMP to produce extracellular inorganic pyrophosphate (PPi), which inhibits bone mineralization and soft tissue calcification. ENPP1 was first reported in relation to autosomal recessive generalized arterial calcification of infancy, hypophosphatemic rickets, and pseudoxanthoma elasticum in 2003 (Rutsch et al., PMID: 12881724). The disorder is characterized by infantile onset of arterial calcification and/or narrowing of medium- and large-sized vessels that cause cardiovascular findings. Additional features can include pseudoxanthoma elasticum, periarticular calcifications, rickets, cervical spine fusion, and hearing loss.\nENPP1 has also been associated with autosomal dominant hypopigmentation-punctate palmoplantar keratoderma syndrome, or Cole disease, by Eytan et al. in 2013 (PMID: 24075184). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we identified differences in inheritance pattern and in clinical phenotype between hypopigmentation-punctate palmoplantar keratoderma syndrome and the remaining disorders, where we found no clear difference in the phenotypic variability or molecular mechanism(s) underlying the disease entities. Therefore, the diseases were split into generalized arterial calcification of infancy 1 (OMIM: 208000), which includes autosomal recessive hypophosphatemic rickets and pseudoxanthoma elasticum, and hypopigmentation-punctate palmoplantar keratoderma syndrome (OMIM: 615522). The split curation for autosomal dominant hypopigmentation-punctate palmoplantar keratoderma syndrome has been curated separately. \nEvidence supporting the relationship between ENPP1 and generalized arterial calcification of infancy 1 includes case-level data. Thirteen variants (including 4 nonsense, 3 frameshift, and 6 missense variants in a homozygous or compound heterozygous state) that have been reported in 7 probands from 3 publications (Rutsch et al. 2003, PMID: 12881724; Ruf et al. 2005, Mehta et al. 2012, PMID: 22539483) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is reported to be biallelic loss of function (Ralph et al. 2022, PMID: 35475527). This gene-disease relationship is also supported by several animal models, including zebrafish and mice, that recapitulate many features of the human disease phenotype (Okawa et al. 1998, PMID: 9662402; Takabayashi et al. 2014, PMID: 24770645; Apschner et al. 2014, PMID: 24906371; Li et al. 2014, PMID: 25479107). \nIn summary, ENPP1 is definitively associated with autosomal recessive generalized arterial calcification of infancy 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 06.17.2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0ea9726e-acef-4a04-9024-fc10d8796195","GCISnapshot":"https://genegraph.clinicalgenome.org/r/50cf1e96-1629-41c5-a5db-1c37e8b24aaa","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/50cf1e96-1629-41c5-a5db-1c37e8b24aaa_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2022-06-17T04:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/50cf1e96-1629-41c5-a5db-1c37e8b24aaa_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-10-11T16:36:21.700Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50cf1e96-1629-41c5-a5db-1c37e8b24aaa_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3b30396-1d47-4951-81ba-ff5dc0c94e53_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bc7f6b7-2284-4a17-a97b-5e1453e5a1ad","type":"EvidenceLine","dc:description":"Consanguineous family","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bc7f6b7-2284-4a17-a97b-5e1453e5a1ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Authors demonstrated abolished NPP activity in all variants scored","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2bc7f6b7-2284-4a17-a97b-5e1453e5a1ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","allele":{"id":"https://genegraph.clinicalgenome.org/r/4426862f-aca9-45ba-8e03-d75e4653ec8f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.2677G>T (p.Glu893Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256903"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/e3b30396-1d47-4951-81ba-ff5dc0c94e53","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","rdfs:label":"Rutsch_Family 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/4426862f-aca9-45ba-8e03-d75e4653ec8f"},"detectionMethod":"Used a high-density microsatellite marker panel in first family to identify critical region, then direct sequencing in ENPP1.","firstTestingMethod":"Other","phenotypeFreeText":"Diagnosed with GACI","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2bc7f6b7-2284-4a17-a97b-5e1453e5a1ad_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/4860ac2a-2308-42ce-8a64-dcc5d8e87ead_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d70a5f07-3a3b-460d-9ba9-43d2d4108812","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d70a5f07-3a3b-460d-9ba9-43d2d4108812_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","allele":{"id":"https://genegraph.clinicalgenome.org/r/93b160c5-493b-46c3-9b57-52bc1307a471","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.2713_2717del (p.Lys905AlafsTer16)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4002616"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8bc7cb74-1fb5-4bf5-aba5-c49eff707099","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8bc7cb74-1fb5-4bf5-aba5-c49eff707099_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Authors demonstrated abolished NPP activity in all variants scored.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8bc7cb74-1fb5-4bf5-aba5-c49eff707099_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a633094-81fa-4af5-bc24-ca9f22040cea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.1441C>T (p.Arg481Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4002225"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4860ac2a-2308-42ce-8a64-dcc5d8e87ead","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","rdfs:label":"Rutsch_Family 6","allele":[{"id":"https://genegraph.clinicalgenome.org/r/93b160c5-493b-46c3-9b57-52bc1307a471"},{"id":"https://genegraph.clinicalgenome.org/r/0a633094-81fa-4af5-bc24-ca9f22040cea"}],"detectionMethod":"Used a high-density microsatellite marker panel in first family to identify critical region, then direct sequencing in ENPP1.","firstTestingMethod":"Other","phenotypeFreeText":"Diagnosed with GACI","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8bc7cb74-1fb5-4bf5-aba5-c49eff707099_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d70a5f07-3a3b-460d-9ba9-43d2d4108812_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/473102aa-70d0-45fe-b190-ef39e4bdd7f7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4f7eaf8-14a9-41d9-ab0d-f2458e2aa287","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4f7eaf8-14a9-41d9-ab0d-f2458e2aa287_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","allele":{"id":"https://genegraph.clinicalgenome.org/r/c641419d-2161-4948-b03b-818a3734c33d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.1094del (p.Pro365HisfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580075082"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5b972b46-6005-4e98-8750-3c7509363591","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b972b46-6005-4e98-8750-3c7509363591_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","allele":{"id":"https://genegraph.clinicalgenome.org/r/89068946-90fc-4356-99cb-5b4f3b799208","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.913C>A (p.Pro305Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342717"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/473102aa-70d0-45fe-b190-ef39e4bdd7f7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","rdfs:label":"Ruf_Family 3","allele":[{"id":"https://genegraph.clinicalgenome.org/r/89068946-90fc-4356-99cb-5b4f3b799208"},{"id":"https://genegraph.clinicalgenome.org/r/c641419d-2161-4948-b03b-818a3734c33d"}],"detectionMethod":"With a set of 27 primer pairs they amplified all 25 exons including the promoter region and their flanking splice sites of ENPP1 from genomic DNA by PCR.","firstTestingMethod":"PCR","phenotypeFreeText":"Diagnosed with GACI","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b4f7eaf8-14a9-41d9-ab0d-f2458e2aa287_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5b972b46-6005-4e98-8750-3c7509363591_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/8ea0c6da-70cf-4961-a25e-1ba1aa604d15_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0ec7a02-d251-4128-ae9e-8c57c013aa03","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0ec7a02-d251-4128-ae9e-8c57c013aa03_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","allele":{"id":"https://genegraph.clinicalgenome.org/r/89068946-90fc-4356-99cb-5b4f3b799208"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6510423d-737e-44ac-a60f-21bc037434e9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6510423d-737e-44ac-a60f-21bc037434e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","allele":{"id":"https://genegraph.clinicalgenome.org/r/0c3b2ede-6728-4a1e-9acf-d549a53a0873","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.749C>T (p.Pro250Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4001996"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8ea0c6da-70cf-4961-a25e-1ba1aa604d15","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","rdfs:label":"Ruf_Family 4","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0c3b2ede-6728-4a1e-9acf-d549a53a0873"},{"id":"https://genegraph.clinicalgenome.org/r/89068946-90fc-4356-99cb-5b4f3b799208"}],"detectionMethod":"With a set of 27 primer pairs they amplified all 25 exons including the promoter region and their flanking splicesites of ENPP1 from genomic DNA by PCR.","firstTestingMethod":"PCR","phenotypeFreeText":"Presents with GACI","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/6510423d-737e-44ac-a60f-21bc037434e9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b0ec7a02-d251-4128-ae9e-8c57c013aa03_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/da43908d-7c81-4aec-b03a-ae360a5de280_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13b75150-eb71-4d07-aa5e-8e0cc3639a5a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13b75150-eb71-4d07-aa5e-8e0cc3639a5a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Authors demonstrated abolished NPP activity in all variants scored.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/13b75150-eb71-4d07-aa5e-8e0cc3639a5a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","allele":{"id":"https://genegraph.clinicalgenome.org/r/100bccc1-4fa2-44f9-ac99-745debbb5fd7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.2375A>G (p.Asn792Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4002514"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/feb1eba6-ae6a-4953-aec2-7608fbe119e9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/feb1eba6-ae6a-4953-aec2-7608fbe119e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","allele":{"id":"https://genegraph.clinicalgenome.org/r/194a8f8d-896c-4284-aebd-ddd3b4df98cc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.936T>G (p.Tyr312Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA147934890"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/da43908d-7c81-4aec-b03a-ae360a5de280","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12881724","rdfs:label":"Rutsch_Family 2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/194a8f8d-896c-4284-aebd-ddd3b4df98cc"},{"id":"https://genegraph.clinicalgenome.org/r/100bccc1-4fa2-44f9-ac99-745debbb5fd7"}],"detectionMethod":"Used a high-density microsatellite marker panel in first family to identify critical region, then direct sequencing in ENPP1.","firstTestingMethod":"Other","phenotypeFreeText":"Diagnosed with GACI","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/13b75150-eb71-4d07-aa5e-8e0cc3639a5a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/feb1eba6-ae6a-4953-aec2-7608fbe119e9_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/db84840c-29ff-4992-bd94-4011f5c7218c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d52f630-028f-4a30-98a8-f59b2e4154c7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d52f630-028f-4a30-98a8-f59b2e4154c7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3D modeling showed that Thr319 lies on the protein surface near the binding cleft, with side chains forming hydrogen bonds with the protein backbone; Arg319 was predicted to disrupt the molecular surface and interfere with hydrogen bonding.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5d52f630-028f-4a30-98a8-f59b2e4154c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22539483","allele":{"id":"https://genegraph.clinicalgenome.org/r/2586683d-20c3-471b-9857-48a2b374470c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.956C>G (p.Thr319Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365669200"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9c5ed65b-dc8c-42c2-9df0-d6721d27c8df","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c5ed65b-dc8c-42c2-9df0-d6721d27c8df_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22539483","allele":{"id":"https://genegraph.clinicalgenome.org/r/de807012-c1a2-4d49-b091-eda29d499cbe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.2344C>T (p.Arg782Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365656041"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/db84840c-29ff-4992-bd94-4011f5c7218c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22539483","rdfs:label":"Mehta_proband","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":13,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/de807012-c1a2-4d49-b091-eda29d499cbe"},{"id":"https://genegraph.clinicalgenome.org/r/2586683d-20c3-471b-9857-48a2b374470c"}],"detectionMethod":"Genetic screening failed to demonstrate a PHEX mutation using standard PCR conditions, exon-specific primers and automated sequencing. PHEX dosage analysis by multiplex ligation-dependent probe amplification did not identify deletions or duplications. Sequence analysis of the coding and flanking intronic regions of the FGF23 and DMP1 genes did not identify any pathogenic mutations. Sequence analysis of the ENPP1 gene (25 exons on chromosome 6) identified two variants: a previously unreported missense variant, p.Thr319Arg (c.956C>G), in exon 9 and a heterozygous nonsense mutation, p.Arg782X (c.2344C>T), in exon 23.","firstTestingMethod":"PCR","phenotypeFreeText":"Hypophosphataemic rickets, short stature, severely restricted spinal movement, ossification of the anterior spinal ligament, iliosacral ligament calcification, and Basstrupâ€™s disease","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5d52f630-028f-4a30-98a8-f59b2e4154c7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9c5ed65b-dc8c-42c2-9df0-d6721d27c8df_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/cd36c641-bce5-4708-beec-872d3db276d9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20102cfd-5996-4d71-b14c-4cbfca8103c9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20102cfd-5996-4d71-b14c-4cbfca8103c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a547d47-a862-46fc-9d16-41d42682034d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.783C>G (p.Tyr261Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256909"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c271e693-492e-4fb7-aeb1-9ba39678123d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c271e693-492e-4fb7-aeb1-9ba39678123d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","allele":{"id":"https://genegraph.clinicalgenome.org/r/b20fef67-6b9b-4e06-a379-10e444777f1c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006208.3(ENPP1):c.878_879del (p.Lys293ArgfsTer4)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA819065838"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cd36c641-bce5-4708-beec-872d3db276d9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15605415","rdfs:label":"Ruf_Family 10","allele":[{"id":"https://genegraph.clinicalgenome.org/r/b20fef67-6b9b-4e06-a379-10e444777f1c"},{"id":"https://genegraph.clinicalgenome.org/r/4a547d47-a862-46fc-9d16-41d42682034d"}],"detectionMethod":"With a set of 27 primer pairs they amplified all 25 exons including the promoter region and their flanking splicesites of ENPP1 from genomic DNA by PCR.","firstTestingMethod":"PCR","phenotypeFreeText":"Presented with GACI","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c271e693-492e-4fb7-aeb1-9ba39678123d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/20102cfd-5996-4d71-b14c-4cbfca8103c9_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/50cf1e96-1629-41c5-a5db-1c37e8b24aaa_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50cf1e96-1629-41c5-a5db-1c37e8b24aaa_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cd245e2-5bf6-4778-bbcb-6cceb6c772f3","type":"EvidenceLine","dc:description":"Mouse model downgraded because it doesn't recapitulate the human phenotype exactly","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95802d4c-37be-4e12-9335-3c4a34e9e985","type":"Finding","dc:description":"Like the human phenotype, the mouse shows ossification of the spinal ligaments","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9662402","rdfs:label":"Okawa_Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2cb46ed9-5bd1-48d4-9fba-2f19ee0e6e80","type":"EvidenceLine","dc:description":"Syndromic disorders GCEP downgrades zebrafish model to 1 point because of potential off-target effects of morpholinos","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dca94193-3f8b-4473-b4fb-9b7573e72e4f","type":"Finding","dc:description":"Human phenotype includes ectopic mineralization, early onset perichondrial ossification with calcification in the inter-cranial space, myocardium, and in the skin, and ectopic calcifications in the eye and craniofacial bones","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24906371","rdfs:label":"Apschner_zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f10ea645-4049-4097-9dd6-ae31cae0d961","type":"EvidenceLine","dc:description":"Model was downgraded because it did not fully recapitulate the human phenotype","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72b56670-d23d-4677-8dee-f44fc2bd7a5b","type":"Finding","dc:description":"Like humans, the mice showed mineralization affecting the arterial vasculature","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25479107","rdfs:label":"Li_mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d8f89c98-fec2-4d6f-9ab3-b4f6bac26127","type":"EvidenceLine","dc:description":"Model downgraded because it does not fully recapitulate the human phenotype","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcf418d2-8b15-4c4c-890a-7627569dc6e0","type":"Finding","dc:description":"Like the human phenotype, the mice showed periarticular calcification","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24770645","rdfs:label":"Takabayashi_mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":9203,"specifiedBy":"GeneValidityCriteria8","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Y-9uw4KAUUo","type":"GeneValidityProposition","disease":"obo:MONDO_0008817","gene":"hgnc:3356","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_50cf1e96-1629-41c5-a5db-1c37e8b24aaa-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}